These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2283573)

  • 1. Pain in children and adolescents with sickle cell disease: a descriptive study.
    Walco GA; Dampier CD
    J Pediatr Psychol; 1990 Oct; 15(5):643-58. PubMed ID: 2283573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Pain; 2003 Mar; 102(1-2):187-93. PubMed ID: 12620610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia.
    Heath LE; Heeney MM; Hoppe CC; Adjei S; Agbenyega T; Badr M; Masera N; Zhou C; Brown PB; Jakubowski JA; Dampier C
    Clin Trials; 2017 Dec; 14(6):563-571. PubMed ID: 28743191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
    Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L
    J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain in Children and Adolescents With Sickle Cell Disease: Multidimensional Assessment.
    Abadesso C; Pacheco S; Machado MC; Finley GA
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):455-462. PubMed ID: 32925397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
    N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.
    Wagdy R; Suliman H; Bamashmose B; Aidaroos A; Haneef Z; Samonti A; Awn F
    Eur J Pediatr; 2018 Dec; 177(12):1745-1752. PubMed ID: 30194527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.
    Morris CR; Kuypers FA; Lavrisha L; Ansari M; Sweeters N; Stewart M; Gildengorin G; Neumayr L; Vichinsky EP
    Haematologica; 2013 Sep; 98(9):1375-82. PubMed ID: 23645695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
    Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain assessment during a vaso-occlusive crisis in the pediatric and adolescent patient: rethinking practice.
    Schiavenato M; Alvarez O
    J Pediatr Oncol Nurs; 2013; 30(5):242-8. PubMed ID: 23850944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.
    Darbari DS; Onyekwere O; Nouraie M; Minniti CP; Luchtman-Jones L; Rana S; Sable C; Ensing G; Dham N; Campbell A; Arteta M; Gladwin MT; Castro O; Taylor JG; Kato GJ; Gordeuk V
    J Pediatr; 2012 Feb; 160(2):286-90. PubMed ID: 21890147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation.
    Smith TP; Schlenz AM; Schatz JC; Maitra R; Sweitzer SM
    Blood Cells Mol Dis; 2015 Feb; 54(2):155-9. PubMed ID: 25486928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
    Stallworth JR; Jerrell JM; Tripathi A
    Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
    Rousseau V; Morelle M; Arriuberge C; Darnis S; Chabaud S; Launay V; Thouvenin S; Roumenoff-Turcant F; Metzger S; Tourniaire B; Marec-Berard P
    Pain Pract; 2018 Jul; 18(6):788-797. PubMed ID: 29266772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute pancreatitis during sickle cell vaso-occlusive painful crisis.
    Ahmed S; Siddiqui AK; Siddiqui RK; Kimpo M; Russo L; Mattana J
    Am J Hematol; 2003 Jul; 73(3):190-3. PubMed ID: 12827657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.